Disclosed is a nano-layered dual hydroxide-biological factor combined system for promoting nerve regeneration to repair a spinal cord injury. The preparation method therefor comprises: 1) synthesizing a nano-layered dual hydroxide CL1; and 2) co-incubating 10 mg CL1 and 200-2000 ng of biological factors NT3, VEGF or bFGF in a low-speed shaker at 4° C. for 2 hours using an ion exchange method, centrifuging same and then obtaining the precipitate. Experiments on transection and resorption spinal cord injury models show that this combined system has a significant recovery effect on the behavior of model mice, can reconstruct the neural circuit of a damaged area over time and achieves an ideal repair effect with regard to a spinal cord injury.

A method forms an implant with a base body made of a biocorrodible magnesium alloy. The methods make magnesium alloy that contains a plurality of statistically distributed particles, with one or more of the elements Y, Zr, Mn, Sc, Fe, Ni, Co, W, Pt and noble earths with the atomic numbers 57 to 71, or the particles comprise alloys or compounds containing one or more of the elements mentioned. The mean distance of the particles from each other is smaller than the hundredfold mean particle diameter.

A treatment method for zirconium alloy includes performing a surface layer oxidation and removal treatment on a surface layer of zirconium alloy. The surface layer oxidation and removal treatment comprises performing an oxidation treatment on the surface layer of the zirconium alloy to obtain an oxide surface layer, and then removing the oxide surface layer to expose a metal substrate. A method for fabricating a surface oxide ceramic layer of zirconium alloy and a material for a medical implant are also provided.

The present disclosure relates to a biodegradable metal alloy with multiple properties, containing: 0.05-0.15 wt % of calcium; a metal element X having a HCP structure, of a composition not forming a precipitated phase when mixed with magnesium; and magnesium as the remainder.

An embodiment includes a process for treating an abdominal aortic aneurysm (AAA) endoleak with a shape memory polymer (SMP) foam device. First, a bifurcated stent graft is placed within the aneurysm while a micro guidewire is positioned within the aneurysm for future catheter access. Second, after placing the iliac graft extension, a catheter is introduced over wire to deliver embolic foams. Third, embolic foams expand and conform to the aneurysm wall. Fourth, embolic foams create a stable thrombus to prevent endoleak formation by isolating peripheral vessels from the aneurysm volume.

A composition and medical implant made therefrom, the composition including a thick diffusion hardened zone, and preferably further including a ceramic layer. Also provided are orthopedic implants made from the composition, methods of making the composition, and methods of making orthopedic implants from the composition.

A medical device includes a device body preferably made of a material susceptible to corrosion or biodegradation and a shellac coating. The device body is at least partially covered by the shellac coating. The shellac coating has a thickness from 0.1 μm to 20 μm. A method for manufacturing the medical device includes the steps of providing the device body and applying the shellac coating onto a surface of the device body.

The invention discloses a preparation method and application of an oxidized ceramic layer on the surface of zirconium and zirconium alloy. The method comprises the following steps: reducing the roughness of a target area to 0.01 μm or less, performing oxidation treatment in an oxidizing gas atmosphere, and replacing the oxidizing gas with inactive gas. According to the technical solution provided in the present application, the surface roughness is controlled before oxidation treatment, so that the surface roughness after oxidation treatment can satisfy the use requirements; and the inert gas replacement after surface oxidation treatment avoids the removal of a film layer with poor performance formed during the cooling process, thereby completely avoiding the need for later polishing treatment, maintaining the integrity and uniformity of the oxidized ceramic layer, and guaranteeing the protective performance.

A biomedical implant (16, 18) is formed from magnesium (Mg) single crystal (10). The biomedical implant (16, 18) may be biodegradable. The biomedical implant (16, 18) may be post treated to control the mechanical properties and/or corrosion rate thereof said Mg single crystal (10) without changing the chemical composition thereof. A method of making a Mg single crystal (10) for biomedical applications includes filling a single crucible (12) with more than one chamber with polycrystalline Mg, melting at least a portion of said polycrystalline Mg, and forming more than one Mg single crystal (10) using directional solidification.

Gold implant having a cross-section in the range of 20-100, preferably in the range of 20-40 μm for use in therapy to prevent or reduce capsular contracture. Further, the invention relates to a method of producing a gold-coated implant.